tranexamic acid Flashcards
1
Q
Classification
TXA
A
- haemostatic
- antifibrinolytic agent
2
Q
Pharmacodynamic
TXA
A
- prevents clot degradation by competing for TPA receptor sites
- inhibits plasminogen conversion to plasmin
3
Q
Pharmacokinetics
TXA
A
IV onset - immediate peak - 3hrs duration - 3hrs
4
Q
INDICATIONs
TXA
A
[PCP]
- signs of shock // hypotension - assoc. w/ injury suggestive of occult or ongoing bleeding
cliniCALL required
maternal vaginal hemorrhage >19 weeks // postpartum hemorrhage
5
Q
CONTRAINDICATIONs
TXA
A
- HYPERSENSITIVITY
- TIME since injury >3HRs
- GI bleed
- Not for actual/estimated age <12
6
Q
ADVERSE EFFECTs
TXA
A
- if administered rapidly, may potentiate hypotension
7
Q
Dosage - Adult
TXA
A
[PCP] 1g IV - over 10mins
NS 50mL - 1gtts/s
NS 250mL - 5gtts/s (open)
IV USE ONLY
8
Q
Dosage - Pediatric
TXA
A
[PCP] 1g IV - over 10mins
NS 50mL - 1gtts/s
NS 250mL - 5gtts/s (open)
IV USE ONLY